(Q33585391)

28 July 2017

1 reference

title

Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris (English)

1 reference

28 July 2017

1 reference

N S Gunasekara

1

1 reference

28 July 2017

S Noble

series ordinal

2

1 reference

28 July 2017

publication date

1 February 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

57

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

261-277

1 reference

Absence of pre-dose rebound phenomena with once daily 5-ISMN in a controlled-release formulation

28 July 2017

cites work

1 reference

12 December 2020

Pharmacokinetics of various preparations of organic nitrates

1 reference

12 December 2020

Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris

1 reference

12 December 2020

The effect of isosorbide-5-mononitrate (5-ISMN) Durules on exercise tolerance in patients with exertional angina pectoris. A placebo controlled study

1 reference

12 December 2020

Nitrate tolerance in angina therapy. How to avoid it.

1 reference

12 December 2020

Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)

1 reference

12 December 2020

Chronic stable angina pectoris. Strategies for effective drug therapy

1 reference

12 December 2020

Studies on a sustained release principle based on an inert plastic matrix

1 reference

12 December 2020

Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia

1 reference

12 December 2020

Nitrate therapy for stable angina pectoris

1 reference

12 December 2020

Mechanisms of action of nitrates

1 reference

12 December 2020

Short and long-acting oral nitrates for stable angina pectoris

1 reference

12 December 2020

Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate

1 reference

12 December 2020

Efficacy of controlled-release isosorbide-5-mononitrate as adjunctive treatment to beta-blocking agents in patients with stable angina pectoris

1 reference

12 December 2020

Acute and chronic effects of once-daily isosorbide-5-mononitrate on the exercise capacity of patients with angina pectoris treated with a beta-blocking drug

1 reference

12 December 2020

Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris

1 reference

12 December 2020

The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group

1 reference

12 December 2020

Long-acting, marked antiischemic effect maintained unattenuated during long-term interval treatment with once-daily isosorbide-5-mononitrate in sustained-release form

1 reference

12 December 2020

Anti-anginal efficacy of a controlled-release formulation of isosorbide-5-mononitrate once daily in angina patients on chronic beta-blockade

1 reference

12 December 2020

Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology

1 reference

12 December 2020

Relationship between pharmacokinetics and hemodynamic tolerance to isosorbide-5-mononitrate

1 reference

12 December 2020

Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure

1 reference

12 December 2020

Patient compliance with once-daily and twice-daily oral formulations of 5-isosorbide mononitrate: a comparative study

1 reference

12 December 2020

Dose-effect relationship amongst three different sustained-release forms of isosorbide 5-mononitrate in patients with coronary artery disease

1 reference

12 December 2020

Slow-release isosorbide-5-mononitrate--a new once daily therapeutic modality for angina pectoris

1 reference

12 December 2020

Experience of long term treatment and different dosage regimens of isosorbide 5-mononitrate

1 reference

12 December 2020

Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. IMDUR Study Group

1 reference

12 December 2020

Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation

1 reference

12 December 2020

Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group

1 reference

12 December 2020

Sustained effect of and lack of development of tolerance to controlled-release isosorbide-5-mononitrate in chronic stable angina pectoris

1 reference

12 December 2020

The nitrovasodilators. New ideas about old drugs

1 reference

12 December 2020

Antianginal efficacy and tolerability of 50 mg sustained-release isosorbide 5-mononitrate in an open twelve-month observation study

1 reference

12 December 2020

Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris

1 reference

12 December 2020

Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate

1 reference

12 December 2020

Nitrate tolerance--mechanisms and prevention.

1 reference

12 December 2020

Eccentric dosing with isosorbide-5-mononitrate in angina pectoris.

1 reference

12 December 2020

Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group

1 reference

12 December 2020

Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina

1 reference

12 December 2020

Biochemical mechanism of organic nitrate action

1 reference

12 December 2020

Dose-dependent headache response and dilatation of limb and extracranial arteries after three doses of 5-isosorbide-mononitrate

1 reference

12 December 2020

Medical therapy of stable angina pectoris

1 reference

12 December 2020

Isosorbide 5-mononitrate pharmacokinetics

1 reference

12 December 2020

Various administration forms of nitrates and their possibilities

1 reference

12 December 2020

Effect of food on the oral bioavailability of isosorbide-5-mononitrate administered as an extended-release tablet

1 reference

12 December 2020

Counterregulatory responses: sustained-release isosorbide-5-mononitrate versus transdermal nitroglycerin

1 reference

12 December 2020

Development of long-acting nitrate delivery systems

1 reference

12 December 2020

Long-term survival in medically treated patients with ischaemic heart disease and prognostic importance of clinical and electrocardiographic data (the Italian CNR Multicentre Prospective Study OD1).

1 reference

12 December 2020

10.2165/00003495-199957020-00016

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1017150548

0 references

1 reference